期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Drug-Drug Interaction Studies of Levocetirizine with Atenolol
1
作者 Shafaque Mehboob Muhammad Azhar Mughal +3 位作者 Khalid Aftab MoonaMehboob Khan Najma Sultana Syed Arayne 《Journal of Pharmacy and Pharmacology》 2017年第3期118-124,共7页
The objective of the study was to evaluate the drug-drug interaction studies of levoceterizine with atenolol. Calibration curve studies of working standard solutions of levocetirizine and atenolol (0.01-0.1 mmol) we... The objective of the study was to evaluate the drug-drug interaction studies of levoceterizine with atenolol. Calibration curve studies of working standard solutions of levocetirizine and atenolol (0.01-0.1 mmol) were scanned. Maxima appeared at 231 nm for levocetirizine and 224 nm for atenolol. The calibration curve obeyed Beer Lambert's Law. Lone availabilities of both the drugs were studied in pH 1, pH 4, pH 7.4 and pH 9 at 37℃ on B.P. (British Pharmacopoeia) dissolution apparatus. To study the drug-drug interaction of levocetirizine (5 mg tablet) and atenolol (100 mg tablet), both the drugs were introduced to the dissolution apparatus in simulated gastric juice (pH 1), pH 4, pH 7.4 and pH 9 at 37℃ at zero time and measured the absorbance maxima of both the drugs at the corresponding wavelength. Graphs were plotted for availability percentage (%) of drug versus time at each set of experiment. The availability percentage (%) of levocetirizine in the buffers of pH simulated to gastric pH 4, pH 7.4 and pH 9 in the presence of atenolol was 436.78%, 376.90%, 436.78% and 436.78%, respectively, but the availability of atenolol was increased up to 214.80%, 212.96%, 214.93% and 231.51% in simulated to gastric pH and in the buffers ofpH 4, pH 7.4 and pH 9, respectively. On the basis of these studies, it is concluded that levocetirizine forms a charge-complex with atenolol; therefore, co-administration of these drugs should be avoided. 展开更多
关键词 levocetirizine ATENOLOL drug-drug interactions absorbance maxima.
下载PDF
新型抗组胺药物治疗变应性鼻炎 被引量:3
2
作者 杨玉成 张楠 Claus Bachert 《中国医学文摘(耳鼻咽喉科学)》 2011年第5期258-259,共2页
1变应性鼻炎与鼻塞症状变应性鼻炎(AR)是一种常见的变应性炎症疾病,全世界人口患病率为10%~25%,有些国家高达40%。中国大陆地区11个中心城市的电话问卷调查显示AR的平均患病率为11%[1]。鼻塞是AR的主要症状,也是患者认为最烦恼的症状。
关键词 鼻炎 变应性 常年性(Rhinitis ALLERGIC Perennial) 鼻炎 变应性 季节性(Rhinitis ALLERGIC Seasonal) 鼻塞(Nasal Obstruction) 组胺H1拮抗剂(Histamine H1 Antagonists) 地氯雷他定(deslolratadine) 非索非那定(fexofenadine) 左西替利嗪(levocetirizine)
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部